Literature DB >> 18620989

Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India.

R Gupta1, V Seethalakshmi, N A Jambhekar, S Prabhudesai, N Merchant, A Puri, M Agarwal.   

Abstract

Over 20 years, 470 cases of giant cell tumor of bone diagnosed at a tertiary cancer hospital were analyzed. Male predominance (57%), predilection for bones around the knee joint (42%), and occurence in the 21- to 30-year-old age group (49.1%) with 6% being in the immature skeleton are well known facts. Accurate diagnosis was possible in 66% and 88% of cases on radiology and biopsy, respectively. Tumors measured 6 to 20 cm and, in 402 cases, showed "usual" histology comprising uniformly scattered multinucleate giant cells amidst mononuclear stromal cells, together imparting a syncitium-like appearance. Presence of osteoid, hemorrhage, and aneurysmal bone cyst-like areas; spindle cells in sheets (devoid of giant cells); or storiform pattern and intravascular osteoclasts were less common. The less common histologic features posed diagnostic difficulty in the setting of a small biopsy. Treatment included intralesional curettage (33.19%), marginal excision (4.2%), wide excision (31%), or radical surgeries (14.25%). Recurrences seen in 170 cases were multiple in 47 cases. Metastases largely to the lung were recorded in 24 cases. The histology of all the tumors, namely, primary, recurrent, or metastatic was identical. Statistical analysis using the computer software SPSS (SPSS Inc, Chicago, Ill)was performed with particular reference to the unusual histologic features vs recurrence and metastasis by chi(2) test. The only statistically significant factors were occurrence in the axial skeleton vs appendicular skeleton (P = .001) and primary treatment elsewhere vs at this hospital (P = .045), each of these being associated with increased frequency for local recurrence but not metastasis.

Entities:  

Mesh:

Year:  2008        PMID: 18620989     DOI: 10.1016/j.anndiagpath.2007.09.002

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  28 in total

1.  The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.

Authors:  Wendi O'Connor; Megan Quintana; Scott Smith; Monte Willis; Jordan Renner
Journal:  J Radiol Case Rep       Date:  2014-06-30

2.  Treatment and outcome of primary aggressive giant cell tumor in the spine.

Authors:  Huabin Yin; Xinghai Yang; Wei Xu; Binbin Li; Bo Li; Ting Wang; Tong Meng; Peng Wang; Tielong Liu; Wang Zhou; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-01-29       Impact factor: 3.134

Review 3.  Giant cell tumor of bone: current treatment options.

Authors:  Keith M Skubitz
Journal:  Curr Treat Options Oncol       Date:  2014-09

Review 4.  Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.

Authors:  Hidetaka Yamamoto; Shin Ishihara; Yu Toda; Yoshinao Oda
Journal:  Med Mol Morphol       Date:  2019-11-20       Impact factor: 2.309

5.  Retrospective analysis of patients with rare-site and metastatic giant cell tumor.

Authors:  Junling Liu; Han Yang; Rui Sun; Zhijun Yang; Zhihua Zhu
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

6.  Epidemiological characteristics of primary spinal osseous tumors in Eastern China.

Authors:  Zhenhua Zhou; Xudong Wang; Zhipeng Wu; Wending Huang; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2017-04-04       Impact factor: 2.754

7.  Giant cell tumors that originated in the sternum.

Authors:  Akram Traibi; Abdellatif Boulahya; Hssain Ihrai; Mohamed Oukabli; El Hassane Kabiri
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-02-10

8.  Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.

Authors:  Bharat Rekhi; Vivek Verma; Ashish Gulia; Nirmala A Jambhekar; Subhash Desai; Shashikant L Juvekar; Jyoti Bajpai; Ajay Puri
Journal:  Pathol Oncol Res       Date:  2016-10-08       Impact factor: 3.201

Review 9.  Giant-cell tumor of bone, anti-RANKL therapy.

Authors:  Armelle Dufresne; Olfa Derbel; Philippe Cassier; Gualter Vaz; Anne-Valérie Decouvelaere; Jean-Yves Blay
Journal:  Bonekey Rep       Date:  2012-09-05

10.  [Pathologic fracture of the distal femur in total knee arthroplasty. Polyethylene-wear-induced osteolysis? A case report].

Authors:  M Napp; M Frank; M Witt
Journal:  Orthopade       Date:  2009-10       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.